Market Tracker

10/20 5:16pm ET

Fortress Biotech Inc (NASDAQ:FBIO)

3.98
Delayed Data
As of Oct 20
 -0.31 / -7.23%
Today’s Change
1.88
Today|||52-Week Range
5.13
+47.41%
Year-to-Date
No recent news for Fortress Biotech Inc.

Today’s Trading

Previous close4.29
Today’s open4.36
Day’s range3.95 - 4.36
Volume269,212
Average volume (3 months)182,236
Market cap$201.1M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-11.29%
Earnings growth (this year)-18.12%
Earnings growth (next 5 years)+26.22%
Revenue growth (last year)+1,809.62%
P/E ratioNM
Price/Sales6.55
Price/Book5.06

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.24-3.76%
SBBPStrongbridge Biophar...+0.15+2.50%
CPRXCatalyst Pharmaceuti...+0.14+5.34%
NBRVNabriva Therapeutics...-0.31-4.67%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$16.5M
Annual profit (last year)-$55.1M
Net profit margin-334.31%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lindsay Allan Rosenwald
Chief Financial Officer
Robyn Hunter
Corporate headquarters
New York, New York

Forecasts